S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
NASDAQ:ECOR

electroCore News Headlines

$0.64
-0.04 (-5.88%)
(As of 01/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.59
$0.68
50-Day Range
$0.54
$0.88
52-Week Range
$0.52
$3.63
Volume
483,458 shs
Average Volume
6.26 million shs
Market Capitalization
$45.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.05
Get electroCore News Delivered to You Automatically

Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

electroCore Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ECOR
News Sentiment

0.33

0.25

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ECOR Articles
This Week

6

4

ECOR Articles
Average Week



electroCore (NASDAQ:ECOR) News Headlines Today

SourceHeadline
finance.yahoo.com logoelectroCore, Inc. Announces Three Abstracts to be Presented at International Stroke Conference 2022 - Yahoo Finance
finance.yahoo.com - January 27 at 8:16 PM
MarketBeat logo Analysts Anticipate electroCore, Inc. (NASDAQ:ECOR) to Post -$0.07 Earnings Per Share
americanbankingnews.com - January 27 at 10:14 AM
globenewswire.com logoelectroCore, Inc. Announces Three Abstracts to be Presented - GlobeNewswire
globenewswire.com - January 25 at 10:00 AM
finance.yahoo.com logoelectroCore, Inc. Announces Three Abstracts to be Presented at International Stroke Conference 2022
finance.yahoo.com - January 25 at 10:00 AM
MarketBeat logoelectroCore (NASDAQ:ECOR) Price Target Cut to $2.75 by Analysts at HC Wainwright
americanbankingnews.com - January 19 at 9:31 AM
globenewswire.com logoelectroCore Announces Shareholder Letter and Full-Year 2021 - GlobeNewswire
globenewswire.com - January 18 at 5:30 PM
finance.yahoo.com logoelectroCore Announces Shareholder Letter and Full-Year 2021 Business Update - Yahoo Finance
finance.yahoo.com - January 18 at 12:29 PM
finance.yahoo.com logoECOR: New Distribution Agreements Complement E-Commerce Initiative
finance.yahoo.com - January 18 at 12:29 PM
finance.yahoo.com logoelectroCore Announces Shareholder Letter and Full-Year 2021 Business Update
finance.yahoo.com - January 18 at 12:29 PM
stocknews.com logoIs electroCore a Good Stock to Add to Your Healthcare Portfolio?
stocknews.com - January 14 at 12:34 PM
globenewswire.com logoSpinal Cord Stimulators Market is Contemplated to Surge at - GlobeNewswire
globenewswire.com - January 13 at 11:01 PM
benzinga.com logoElectroCore's Vagus Nerve Stimulator Wins Breakthrough Device Tag For Stress Disorder - Benzinga - Benzinga
benzinga.com - January 13 at 8:00 AM
benzinga.com logoelectroCore's gammaCore Non-Invasive Vagus Nerve Stimulation Receives Breakthrough Device Designation For Treatment Of Posttraumatic Stress Disorder - Benzinga
benzinga.com - January 12 at 11:58 AM
finance.yahoo.com logogammaCore™ Non-Invasive Vagus Nerve Stimulation(nVNS) Receives Breakthrough Device Designation for Treatment of Posttraumatic Stress Disorder (PTSD)
finance.yahoo.com - January 12 at 11:58 AM
globenewswire.com logoelectroCore, Inc. Broadens Patient Access to gammaCore with - GlobeNewswire
globenewswire.com - January 11 at 9:04 AM
finance.yahoo.com logoelectroCore, Inc. Broadens Patient Access to gammaCore with Launch of U.S. Telehealth Portal and Online Store
finance.yahoo.com - January 11 at 9:04 AM
globenewswire.com logoelectroCore Announces Publication of PREMIUM II Trial of - GlobeNewswire
globenewswire.com - January 10 at 6:02 PM
finance.yahoo.com logoelectroCore Announces Publication of PREMIUM II Trial of gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) for the Prevention of Migraine
finance.yahoo.com - January 10 at 6:02 PM
MarketBeat logo$1.70 Million in Sales Expected for electroCore, Inc. (NASDAQ:ECOR) This Quarter
americanbankingnews.com - January 8 at 1:14 AM
seekingalpha.com logoelectroCore: Pioneering Bioelectronic Medicine - Seeking Alpha
seekingalpha.com - January 6 at 3:52 PM
finance.yahoo.com logoelectroCore to Present at H.C. Wainwright BIOCONNECT Virtual Conference
finance.yahoo.com - January 4 at 9:17 AM
benzinga.com logoelectroCore Offers Update On Non-Invasive Vagal Nerve Stimulation Candidate To Treat Post Traumatic Stress Disorder - Benzinga
benzinga.com - December 16 at 6:58 PM
globenewswire.com logoelectroCore, Inc. Provides Update on Global Distribution Partners - GlobeNewswire
globenewswire.com - December 16 at 8:57 AM
finance.yahoo.com logoelectroCore, Inc. Provides Update on Global Distribution Partners
finance.yahoo.com - December 16 at 8:57 AM
streetinsider.com logoelectroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder - StreetInsider.com
streetinsider.com - December 15 at 10:51 PM
globenewswire.com logoelectroCore, Inc. Announces The Launch of a New Online Shop - GlobeNewswire
globenewswire.com - December 15 at 12:44 PM
finance.yahoo.com logoelectroCore, Inc. Announces The Launch of a New Online Shop in the United Kingdom
finance.yahoo.com - December 15 at 12:44 PM
globenewswire.com logoelectroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder - GlobeNewswire
globenewswire.com - December 14 at 3:44 PM
finance.yahoo.com logoelectroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder
finance.yahoo.com - December 14 at 10:13 AM
globenewswire.com logoelectroCore Announces New Patent for Stroke and TIA Treatment - GlobeNewswire
globenewswire.com - December 13 at 1:26 PM
finance.yahoo.com logoelectroCore Announces New Patent for Stroke and TIA Treatment
finance.yahoo.com - December 13 at 1:26 PM
businesswire.com logoGlobal Migraine Market to 2025 - Insights, Competitive Landscape and Forecasts - ResearchAndMarkets.com - Business Wire
businesswire.com - December 9 at 3:19 PM
globenewswire.com logoelectroCore to Participate at Canaccord Genuity MedTech & - GlobeNewswire
globenewswire.com - November 11 at 9:27 AM
finance.yahoo.com logoelectroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum
finance.yahoo.com - November 11 at 9:27 AM
finance.yahoo.com logoECOR: Third Quarter Results
finance.yahoo.com - November 8 at 3:42 PM
seekingalpha.com logoelectroCore, Inc. (ECOR) CEO Daniel Goldberger on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 7 at 8:26 AM
finance.yahoo.com logoelectroCore Announces Third Quarter 2021 Financial Results - Yahoo Finance
finance.yahoo.com - November 5 at 2:12 PM
globenewswire.com logoelectroCore Announces Third Quarter 2021 Financial Results - GlobeNewswire
globenewswire.com - November 4 at 5:57 PM
finance.yahoo.com logoelectroCore Announces Third Quarter 2021 Financial Results
finance.yahoo.com - November 4 at 5:57 PM
nasdaq.com logoelectroCore (NASDAQ:ECOR) Is In A Good Position To Deliver On Growth Plans - Nasdaq
nasdaq.com - November 4 at 12:56 PM
finance.yahoo.com logoQuite a few insiders invested in electroCore, Inc. (NASDAQ:ECOR) last year which is positive news for shareholders
finance.yahoo.com - November 4 at 12:56 PM
finance.yahoo.com logoelectroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th
finance.yahoo.com - October 21 at 1:04 PM
finance.yahoo.com logoelectroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England - Yahoo Finance
finance.yahoo.com - October 20 at 1:18 PM
globenewswire.com logoelectroCore Announces Publication Reviewing the Prescribing - GlobeNewswire
globenewswire.com - October 20 at 8:18 AM
finance.yahoo.com logoelectroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England
finance.yahoo.com - October 20 at 8:18 AM
benzinga.com logoelectroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine - Benzinga - Benzinga
benzinga.com - October 15 at 5:46 PM
globenewswire.com logoelectroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine - GlobeNewswire
globenewswire.com - October 14 at 9:54 AM
finance.yahoo.com logoelectroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine
finance.yahoo.com - October 14 at 9:54 AM
globenewswire.com logoelectroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance - GlobeNewswire
globenewswire.com - October 12 at 9:17 AM
finance.yahoo.com logoelectroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance
finance.yahoo.com - October 12 at 9:17 AM
Get electroCore News Delivered to You Automatically

Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.